Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5730
Title: To Evaluation of Effectiveness of Chelatory Therapy in Patients with Talassemia
Authors: Zaynutdinova D.L., Qudratova M.F., Qo’ziyeva M.G., Muhammadaminova D.R., Axtamov A.J.
Keywords: anemia, hemoglobinopathy, thalassemia, hemosiderosis
Issue Date: 2022
Publisher: USA
Series/Report no.: УДК;
Abstract: The term “thalassemia” refers to a group of autosomal-recessive blood diseases charaeterized by a decrease in the synthesis of one of two types of polypeptide chains of globin (α or β), that form a molecule of adult hemoglobin(HbA, α2β2). This leads to a decrease in the filling of erythrocytes with hemoglobin and anemia. In Uzbekistan, the birth rate with this disease is 10-15 per year. At present in the Republic of Uzbekistan, 184 patients with thalassemia are registered at the Research Institute of Hematology and Blood Transfuzion at the Dispensary
URI: http://repository.tma.uz/xmlui/handle/1/5730
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
Zaynutdinova D.L. O'zbek.pdfTo Evaluation of Effectiveness of Chelatory Therapy in Patients with Talassemia449.15 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.